Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Attention to doping controls required when prescribing for athletes.

Johnston AM.

Chest. 2006 Oct;130(4):1283-4. No abstract available.

PMID:
17035475
2.

Drug testing of athletes.

Uzych L.

Br J Addict. 1991 Jan;86(1):25-31.

PMID:
2009393
3.

Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.

Smith R, Barnsley L, Kannangara S, Mace A.

Rheumatology (Oxford). 2004 Dec;43(12):1473-5. Epub 2004 Aug 3. Review.

PMID:
15292526
4.

Is it legal? Prescribing for the athlete.

Sando BG.

Aust Fam Physician. 1999 Jun;28(6):549-53.

PMID:
10399386
5.

Testing athletes, and banning those who take drugs, is unjustifiable.

Shuster S.

BMJ. 2012 May 22;344:e3521. doi: 10.1136/bmj.e3521. No abstract available.

PMID:
22619216
6.

Impact of changes in anti-doping regulations (WADA Guidelines) on asthma care in athletes.

Couto M, Horta L, Delgado L, Capão-Filipe M, Moreira A.

Clin J Sport Med. 2013 Jan;23(1):74-6. doi: 10.1097/JSM.0b013e31826869ef.

PMID:
22948449
7.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H, Schänzer W.

Drug Test Anal. 2013 Jan;5(1):1-19. doi: 10.1002/dta.1441. Epub 2012 Dec 10. Review.

PMID:
23229872
8.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H, Schänzer W.

Drug Test Anal. 2012 Jan;4(1):2-16. doi: 10.1002/dta.415. Review.

PMID:
22287289
9.

[Asthma drugs and doping].

Pillard F, Rolland Y, Rivière D.

Allerg Immunol (Paris). 1999 Nov;31(9):317-9. Review. French.

PMID:
10615514
10.

Performance-enhancing drug use.

Green GA.

Orthopedics. 2009 Sep;32(9). pii: orthosupersite.com/view.asp?rID=43204. doi: 10.3928/01477447-20090728-39. Review.

PMID:
19751025
11.

Doping taboos.

Sperryn P.

Br J Sports Med. 1995 Jun;29(2):75. No abstract available.

12.

Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.

Fitch K.

Clin Med (Lond). 2012 Jun;12(3):257-60. Review.

PMID:
22783779
13.

[Doping-related problems in clinical practice].

Villiger B, Monnat A.

Ther Umsch. 2001 Apr;58(4):232-8. Review. German.

PMID:
11344955
14.

[Discussion of public health and decriminalization of doping].

Pedraz MV.

Rev Saude Publica. 2013 Oct;47(5):1011-4. Spanish.

15.

Treating the elite athlete: anti-doping information for the health professional.

Tandon S, Bowers LD, Fedoruk MN.

Mo Med. 2015 Mar-Apr;112(2):122-8. Review.

PMID:
25958657
16.

How we do it: ENT prescribing to competitive athletes--a review of current regulations.

Mace A, Smith R, Sandhu G.

Clin Otolaryngol. 2005 Apr;30(2):201-5. No abstract available.

PMID:
15839878
17.

Drug testing effectiveness in identifying and preventing drug use.

Coombs RH, Ryan FJ.

Am J Drug Alcohol Abuse. 1990;16(3-4):173-84.

PMID:
2288319
18.

Keeping it Clean.

Mahaffey BL.

Mo Med. 2015 May-Jun;112(3):171. No abstract available.

PMID:
26168583
19.

Back to the game: how Congress can help sports leagues shift the focus from steroids to sports.

Saka JM.

J Contemp Health Law Policy. 2007 Spring;23(2):341-63. No abstract available.

PMID:
17642385
20.

Supplemental Content

Support Center